Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: FDA advisory panel recommends approval of TB Alliance's TB treatment, innovation in women's health, and British syringe-free vaccine maker set to shake up the industry

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Ushering in Advancements for Women’s Health

Dr. Bríd Devlin is the executive vice president of product development of the International Partnership for Microbicides (IPM), a GHTC member. In this guest post, she writes about a new study IPM launched last week that will look at a new HIV prevention option for women.

Read More
Reducing child deaths worldwide must involve research

Combating preventable child deaths worldwide is an “investment that will pay dividends for years to come,” Deputy National Security Advisor Dennis McDonough said last week at a major conference at Georgetown University.

GHTC
Read More
PATH/Evelyn Hockstein
Follow Breakthroughs for the latest R&D news from AIDS 2012

The biennial gathering of the world’s top HIV/AIDS scientists, advocates, and policymakers comes on the heels of some of the most significant research results for new HIV prevention and treatment tools in recent years, and the Breakthroughs blog will be at the conference from July 22 to 27, reporting on these research and development (R&D) advances.

GHTC
Read More
PATH/Nguyen Ba Quang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Advisory panel, Congress move to advance FDA’s role in global health

Recently, a US Food and Drug Administration (FDA) panel recommended that the HIV/AIDS drug Truvada be approved for HIV prevention among certain groups at risk of infection.

GHTC
Read More
PATH/Francesca Holme
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Developing a novel vaccine against tuberculosis: A conversation with Dr. Steven Reed

Dr. Steven Reed is the founder, president, and chief scientific officer of the Infectious Disease Research Institute (IDRI), located in Seattle, Washington.

Aeras
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
UPDATE: House Appropriations Committee approves SFOPs legislation

Late last week, the House Appropriations Committee debated and approved Fiscal Year (FY) 2013 appropriations legislation for the State and Foreign Operations (SFOPS) account, which includes funding levels for the State Department and the US Agency for International Development (USAID).

GHTC
Read More
Modeling Potential Impact on HIV Vaccine Awareness Day

Margaret McGlynn is the president and CEO of the International AIDS Vaccine Initiative (IAVI). In this guest post to mark HIV Vaccine Awareness Day, she writes about the potential impact of a safe and effective HIV vaccine around the world. The post originally appeared on the US Agency for International Development’s (USAID) Impact blog.

Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Event examines new WHO report on global health R&D

Soma Ghoshal is a program officer with the Results for Development Institute. In this guest post, she writes about a recent event that examined a new World Health Organization (WHO) report on global health research and development (R&D) financing.

Read More
House budget bill has mixed results for USAID and global health

On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and US Agency for International Development (USAID).

GHTC
Read More
New NIH program could speed innovations for patients in need worldwide

Late last week, the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) unveiled a pilot program that aims to speed the creation of new drugs.

GHTC
Read More
Research experts stress why investing in R&D works for the US and the world

With the ever-present specter of federal budget reductions that could impact global health and development programs, the GHTC’s event on Friday to launch our new report couldn’t have come at a better time.

GHTC
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New report confirms that US investments in global health research are paying off

Did you know that Americans spend more money on ice cream in three weeks than the US Government spends on global health research and development (R&D) in a year? And despite this relatively modest investment in the creation of new global health tools, the United States is the worldwide leader in R&D for neglected diseases.

GHTC
Read More
PATH/Aaron Joel Santos
What could you prove with $100,000?

Michel Zaffran is the coordinator for the Expanded Programme on Immunization at the World Health Organization (WHO). He is also the director of Project Optimize at PATH. In this guest post, Zaffran writes about how the Bill & Melinda Gates Foundation is seeking new ideas for immunization systems and vaccine product characteristics.

PATH
Read More
Investment in Malaria R&D Required to Sustain Gains and Save Lives

In this guest post, Mandy Goldberg from Research!America writes about an event today in Washington, DC, that focuses on research and development (R&D) for new malaria tools. The event is sponsored by Research!America, the Global Health Technologies Coalition (GHTC), and several other partners.

Research!America
Read More